Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Copaxone
Pharma
Teva hit with €463M fine over Copaxone misconduct claims in EU
The European Commission fined Teva 462.6 million euros over claims that it “[abused] its dominant market position to delay competition” to Copaxone.
Fraiser Kansteiner
Oct 31, 2024 10:45am
Teva to pay $450M to settle longstanding kickback allegations
Oct 11, 2024 9:23am
Teva faces fresh Copaxone kickbacks lawsuit
Aug 20, 2024 1:12pm
Viatris, Mapi's long-acting MS drug rebuffed by FDA
Mar 11, 2024 11:11am
Teva granted pretrial appeal in high-stakes kickbacks case
Nov 21, 2023 9:35am
Teva delays high-stakes kickbacks trial with rare early appeal
Aug 16, 2023 4:19pm
